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We are thankful to Dr. Denner for giving us the opportunity to
provide additional details on our study and hypotheses that
were not possible to include due to the limited size of our
original article.
We know, and stated, that retroviral endogenization cor-
responds to integration of exogenous retrovirus DNA into
host germ cells. Our hypothesis that HIV was en route to
endogenization in two patients incepted from combined recent
evidence. The ﬁrst evidence is the discovery that the most
ancient mechanism of defence against viral infections described
so far in living organisms consists of the integration in the ge-
nomes of fragments of viral DNA from bacteria and archaea,
organized as clustered regularly interspaced short palindromic
repeats (CRISPRs) [1] (Fig. 1a). In parallel, it has been revealed
since the advent of genomics that endogenized retroviral DNA
was present, in the vast majority of cases as ancient degraded
footprints, in all vertebrate genomes analyzed so far, including
in human DNA [2,3]. In addition, the presence of these
endogenous retroviruses (ERVs) in DNA from some mammalsClinical Microbiology and Infection © 2014 European Society of Cmay protect from exogenous retroviral infections [4,5]. Taken
together, these ﬁndings led us to the assumption that ERVs
were remnants from ancient retroviral epidemics, and that
endogenization of viral sequences, observed in various organ-
isms from the three cellular domains of life, represented
therefore a general mechanism of defence against viruses. This
hypothesis was eventually strengthened by the discovery that
retroviral endogenization is ongoing in koala populations, in
whom both exogenous and endogenous retroviruses coexist,
and is possibly associated with resistance of koala survivors to
these retroviruses [6–8].
Our work showed that HIV inactivation occurred in two
patients who had remained free of detectable virus in their
blood by standard assays as well as of any HIV-related
symptoms, and that this inactivation likely resulted from the
action of apolipoprotein B RNA-editing catalytic component
protein (APOBEC) 3 [9]. We pointed out, as noted by J.
Denner, that the gene encoding Vif, which restricts APO-
BEC3G activity, was inactivated in HIV from one patient,
which probably unleashed the action of this enzyme. APOBEC
belongs with activation-induced deaminase (AID) to a family of
cytidine deaminases that are evolutionary conserved among
vertebrates [10]. Strikingly, phylogeny reconstructions and
in vitro experiments suggested that APOBEC represents an
ancient system of defence of genomes against exogenous vi-
ruses, endogenous viruses, and endogenous retroelements,
and there appears to be a coincidence between the emer-
gence of APOBEC among vertebrates and that of ERVs in
their DNA genome [11]. Regarding APOBEC3G, it underwent
rapid evolution and strong positive selection in primates, and
ancient footprints of the action of this enzyme were reported
in human DNA. Taken together, these data led us to infer that
APOBEC3 is probably key in the inactivation of HIV in
humans, and that such inactivation may represent an early step
of HIV endogenization (Fig. 1b). Moreover, they led us to
speculate that HIV may have had the same fate as former
retroviruses whose remnants were identiﬁed in human DNA,
considering that retrovirus endogenization comprises several
steps, including (1) the emergence of a retroviral epidemic, (2)
the inactivation of retroviral genes, (3) the integration into
host germ-cell DNA of inactivated retroviruses, (4) their
transmission to descent, and (5) the subsequent degradation
of these sequences. Thus, HIV endogenization may have
occurred in some survivors who neutralized the virus,
creating a bottleneck for human populations with inactivated
HIV in their DNA. Whether this might lead to protection,
either of infected individuals or of their descendants as ap-
pears to be the case for some mammals [4,5], includingClin Microbiol Infect 2015; 21: e35–e37




FIG 1. Schematics for viral endogenization as a general defence mechanism against viruses (a) and steps of retrovirus endogenization and fate of
retroviruses and host populations (b). RV, retrovirus.
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this stage.
Certainly, we did not demonstrate in our study all the steps
of such an HIV endogenization process, but only what may be
an early step, which consists of the inactivation of HIV DNA,
and this is what we meant while writing “en route to endoge-
nization” in the title of our article. Koalas themselves, from our
point of view, are on the road to complete neutralization of
retroviruses that assail them. They are the only vertebrates in
which we are observing this mechanism unfold, and we believe
that the history of this epidemic of retroviruses in koalas is not
complete either, but that in few thousand years, only endo-
genized remnants from these retroviruses will be detectable in
koala DNA; these ERVs may allow descendants of the survivors
of current koalas to defend themselves against further invasions
by same or similar viruses. Overall, the study and monitoring of
ongoing retrovirus endogenization in various koala populations
is therefore of great interest, as it may provide a wealth of data
on major stages, timing, and determinants of retroviral
endogenization.
As pointed out by Dr. Denner, although a large majority of
known ERVs present in vertebrate DNA are inactive [12], some
can coexist with exogenous retroviruses, as described among
koalas [7]. In addition, it is proven or suspected that some ERVs
remain capable of expressing replication-competent viruses
[13,14]. Certainly, this issue on the potential of ERVs to be
pathogenic is worthy to note. Finally, regarding the use of the
term “neutralization” in our article, we indeed used it both to
indicate the preclusion of replication of an HIV laboratory strain
by serum samples, which is the conventional meaning, but also
(only once as a matter of fact) to indicate the inactivation of the
virus by the occurrence of stop codons in its genes. In this latter
case, the capability of the virus to encode functional proteins
and replicate is indeed halted. However, we recognize that
other mechanisms, not explored in our article, might also
“neutralize” in vitro the infectivity of HIV in our experiments. If
we agree that the use of this term is not conventional here, HIV
gene inactivation appears, notwithstanding, as a way to
“neutralize” the enemy.Clinical Microbiology and Infection © 2014 European Society of Clinical MicrobiologyTransparency declarationThe authors declare that they have no conﬂicts of interest.References[1] Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E,
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